Medical/Pharmaceuticals
Revolutionary test for male infertility can be a game changer for couples striving to conceive
SINGAPORE, May 5, 2025 /PRNewswire/ -- A simple, but revolutionary test has been developed to help unravel the mystery of infertility among men who display normal semen parameters. Infertility affects an estimated one in every six couples worldwide with male factor prevalent in about half of t...
2025-05-05 09:00
2591
IND Application for NTS071, Nutshell Therapeutics' p53 Y220C Allosteric Reactivator, Received US FDA clearance
SHANGHAI, May 4, 2025 /PRNewswire/ -- On April 23, 2025, Nutshell Therapeutics ( Shanghai ) Co., LTD. received IND clearance from the FDA to initiate Phase 1 clinical trial inthe United States for its NTS071, a novel small molecule allosteric reactivator targeting p53 Y220C mutation. NTS07...
2025-05-04 14:48
3150
A future of reproductive medicine where humanity and trust sit in harmony with spectacular advances in artificial intelligence
SINGAPORE, May 3, 2025 /PRNewswire/ -- Artificial intelligence, or AI, is transforming our lives in dynamic and challenging ways, including the ability to create life. In assisted reproduction, AI and automation tools have taken fertility specialists to new frontiers in precision, efficiency a...
2025-05-03 09:47
4316
Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation
* Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in July * With a fully modular design, CURECATM introduces a bold vision for automating pre-treatment across diverse PCR specimen types * Developed for future integration into unattended work...
2025-05-02 21:00
4703
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
PHILADELPHIA, May 2, 2025 /PRNewswire/ -- Darnatein, a subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), a biotechnology company advancing design-augmented biologics, announced today that it will present scientific data at the14th International Bone Morphogenetic Protein (BMP) Conference, taking ...
2025-05-02 19:30
2866
CPHI South East Asia 2025: Your gateway to ASEAN's expanding pharmaceutical landscape
KUALA LUMPUR, Malaysia, May 2, 2025 /PRNewswire/ -- As Southeast Asia's pharmaceutical industry rapidly evolves—driven by regulatory harmonization, innovation, and growing healthcare demand—CPHI South East Asia 2025 provides a vital platform to connect with regional stakeholders, showcase breakth...
2025-05-02 19:25
4553
Siemens Healthineers unveils MAMMOMAT B.brilliant, a revolutionary mammography system in Indonesia
SURABAYA, Indonesia, May 2, 2025 /PRNewswire/ -- Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to the Global Cancer Observatory, breast cancer accounts for 66,271 new cases (16.2%) out of a tota...
2025-05-02 16:08
3190
How latest genetic data on fertility may be an indicator of chronic disease onset and longevity
SINGAPORE, May 2, 2025 /PRNewswire/ -- Latest population studies have cast new light on genetic influences on women's reproductive lifespans and possible markers for the onset of chronic diseases. Evidence is growing that conditions such as cardiovascular disease, type 2 diabetes, rheumatoid a...
2025-05-02 15:59
3801
AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.
AUCKLAND, New Zealand, May 1, 2025 /PRNewswire/ -- Soft tissue regeneration
company, Aroa Biosurgery, is pleased to announce a milestone in clinical
evidence.
2025-05-02 10:42
3017
HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion
SINGAPORE, May 2, 2025 /PRNewswire/ -- HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million inves...
2025-05-02 10:00
2878
Fertility experts urge the creation of registries to safeguard donor conception practices
SINGAPORE, May 2, 2025 /PRNewswire/ -- Gamete donation has accelerated around the world in the past decade driven in part by the emergence of commercial sperm and egg banks and a growing recognition of the validity of this form of family buildingamong single women in some countries. However, l...
2025-05-02 09:51
2608
VISTA Eye Specialist Celebrates Breakthrough PX Ninety Collaboration with Shareef Mahdavi—Now Featured in Leading U.S. Medical Journal
PETALING JAYA, Malaysia, May 2, 2025 /PRNewswire/ -- Just months after announcing its dynamic partnership with world-renowned patient experience expert Shareef Mahdavi and the PX Ninety program,VISTA Eye Specialist is thrilled to mark a major milestone: the story of its PX Ninety and Ikigai WowX ...
2025-05-02 08:00
2731
FaceHeart Received Another FDA Clearance for its Contactless Video-Based Vital Sign Measurement of Respiratory Rate
* Developed by FaceHeart, FH Vitals SDK-RR has obtained FDA Clearance. This is the second 510(k) class II SaMD (Software as a Medical Device) FaceHeart received from the FDA. * FaceHeart Vitals™ is a video-based, contactless vital sign measurement SDK that can be integrated into devices such ...
2025-05-01 23:06
2830
A global study led by CUHK and the University of Calgary charts four-stage evolution of Inflammatory Bowel Disease
HONG KONG, May 1, 2025 /PRNewswire/ -- An international consortium led by The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and the University of Calgary in Canada has conducted a global epidemiological study on Inflammatory Bowel Disease (IBD). It found that this chr...
2025-05-01 15:05
2974
A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis
SUZHOU, China, May 1, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that a phase II/III clinical trial of anti-HER2 bispecific antibody KN026 (Study ID: KN026-001) in combination with chemother...
2025-05-01 09:49
2962
Preserving fertility and optimising care for the one in seven women suffering from endometriosis
SINGAPORE, May 1, 2025 /PRNewswire/ -- Fertility specialists in the Asia Pacific region are bringing to fruition new standards of care for women and girls suffering from endometriosis and to help preserve the fertility of those with the debilitating condition. They have finalised a rigorous co...
2025-05-01 08:29
2538
S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial
SEOUL, South Korea, May 1, 2025 /PRNewswire/ -- S&E bio Co., Ltd.
2025-05-01 08:00
2719
Natus announces integration of InVisus Pro NMUS into Natus Elite software
MIDDLETON, Wis., May 1, 2025 /PRNewswire/ -- Natus Medical Incorporated has announced its InVisus Pro Neuromuscular Ultrasound system can now be seamlessly integrated with all Natus EMG systems via Natus Elite Software, providing users of the portable, stand-alone neuromuscular ultrasound with th...
2025-05-01 03:15
2720
ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care
Showcasing the future of ophthalmic research at ARVO 2025: * ZEISS Research Data Platform launch - a cloud-based, AI-driven technology solution designed to accelerate discoveries, integrating research and clinical data, and simplifying research workflows. * ZEISS's collaboration with Boehring...
2025-04-30 21:00
2332
JediCare Medical has announced successful completion of its first-in-human feasibility study of the world's first-of-its-kind Pulmonary Nodule Percutaneous Sphere Resection
SHANGHAI, April 30, 2025 /PRNewswire/ -- JediCare Medical Technology Co., Ltd. a Shanghai, China based company ("the Company"), jointly with West China Hospital ofSichuan University, recently announced the successful completion of first-in-human ("FIH") feasibility study of its innovative, proprie...
2025-04-30 21:00
1989
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 315 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 300 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Most Read
Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia
2026-01-20 17:49
7163
